Kim Young-jin promoted to vice-chairman of Handok Aventis Pharma

Published: 2002-03-14 06:57:00

Updated: 2002-03-14 06:57:00

Handok Pharm-Aventis Pharm has recently promoted Kim Young-jin to vice-chairman. Mr. Kim, a graduate of Yonsei University, is a former president of Hankdok Pharm. Crake Kelly has been elected president of Handok-Pharm-Aventis Pharm. Mr. Kelly, formerly director of Hoechst-Marion Loussel, has been...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK